Impact of the Hepatitis C Virus Variability on Liver Steatosis
N/A
18 Years
75 Years
18 Years
75 Years
Not Enrolling
Both
Chronic Hepatitis C
Both
Chronic Hepatitis C
Trial Information
Impact of the Hepatitis C Virus Variability on Liver Steatosis
Inclusion Criteria:
- Patients with chronic hepatitis C, naive of an antiviral treatment or after relapse
or non-response for an antiviral treatment stopped for more than 1 year
- Liver biopsy necessary for the care of the patient
- Signature of informed consent
Exclusion Criteria:
- Patients for which the liver biopsy is estimated ≤ 18 mm, so a portion of 3 mm could
not be devoted for the study
Type of Study:
Observational
Study Design:
Observational Model: Cohort, Time Perspective: Prospective
Principal Investigator
Philippe ROINGEARD
Investigator Role:
Study Director
Investigator Affiliation:
INSERM ERI 19
Authority:
France: Afssaps - Agence française de sécurité sanitaire des produits de santé (Saint-Denis)
Study ID:
AORT08-PR/VIRO-Stéatose
NCT ID:
NCT00843076
Start Date:
January 2009
Completion Date:
April 2011
Related Keywords:
- Chronic Hepatitis C
- Hepatitis
- Hepatitis A
- Hepatitis, Chronic
- Hepatitis C
- Hepatitis C, Chronic
Name | Location |
|---|
